United States · Series B startup

Who invested in Protego Biopharma

One round we have observed, with the 10 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Raised 11 months ago

Funding summaryUpdated 26 Oct 2026

$130Mraised across 1 round since 2025, from 3 sources

Latest round
Series B, $130MDec 2025
Led by
Novartis Venture Fund and Forbion Capital Partners
Investors
10 (2 led)
See who backed them

The rounds

  1. Dec 2025

Everyone who backed them

Novartis Venture FundCorporate VC1round, led 1
Forbion Capital PartnersPrivate equity1round, led 1
MPM CapitalPrivate equity1round
Omega FundsVC firm1round
Digitalis VenturesVC firm1round
Vida VenturesVC firm1round
Droia VenturesVC firm1round
Scripps ResearchVC firm1round
YK BioventuresVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Protego Biopharma as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Vida VenturesVC firmPer its own site

Quick answers about Protego Biopharma

Who invested in Protego Biopharma?

Protego Biopharma's investors include Novartis Venture Fund, Forbion Capital Partners, Lightspeed Venture Partners, MPM Capital and Omega Funds, and 5 more on record. Novartis Venture Fund led its latest round.

How much has Protego Biopharma raised?

Protego Biopharma has raised $130M across 1 round since 2025.

When did Protego Biopharma last raise?

Protego Biopharma's most recent round was a Series B of $130M in Dec 2025, led by Novartis Venture Fund.

What was Protego Biopharma's biggest round?

Its most recent round, $130M in Dec 2025, is also its largest on record.

Who backed Protego Biopharma first?

Protego Biopharma's first round on record, in Dec 2025, was backed by Novartis Venture Fund, Forbion Capital Partners and Lightspeed Venture Partners and 7 others.

What stage is Protego Biopharma at?

Protego Biopharma's latest named round is a Series B, in Dec 2025.

Where is Protego Biopharma based?

Protego Biopharma is based in the United States.

Who led Protego Biopharma's rounds?

Novartis Venture Fund led the Series B in 2025.

Companies like Protego Biopharma

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.